JP Morgan Healthcare Day 2: Abbott, Caris, Danaher, Quest, LabCorp, Luminex, Agilent, Adaptive Bio

Jan 14, 2020

|

SAN FRANCISCO – The 38th annual JP Morgan Healthcare Conference continued on Tuesday with diagnostics companies presenting before thousands of investors. Below are brief reports on the presentations and breakout sessions covered by our team at the conference.

Abbott Laboratories

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

JP Morgan Healthcare Day 2: Abbott, Caris, Danaher, Quest, LabCorp, Luminex, Agilent, Adaptive Bio

To read the full story....

Breaking News

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

Agendia Settles Allegations of Medicare Fraud for $8.25M

Noridian Aligns With Palmetto on Single-Gene, Multi-Gene PGx Test Coverage

Demand for SARS-CoV-2 Diagnostic Tests Drives Sharp Increase in 360Dx Index for First Half of 2020

Sysmex Nabs Japan Approval for Automated Hematology Analyzer to Diagnose Malaria

Centogene Gets Emergency Use Authorization for PCR-Based Coronavirus Test

What's Popular?

Demand for SARS-CoV-2 Diagnostic Tests Drives Sharp Increase in 360Dx Index for First Half of 2020

Accelerate, Invitae Lead Gainers as 360Dx Index Ticks Up in June

NanoDiagnostics Closes $18M Series C Round

InBios International Gets Emergency Use Authorization for Second Coronavirus Antibody Test

FDA Grants EUAs for PCR Coronavirus Tests, Nasal Swab Self-Collection Kit

Sponsorships